Synthesis of peptides for use as immunogens.
Imperial Cancer Research Fund, London, UK.
D C
DC
Hancock
N J
NJ
O'Reilly
G I
GI
Evan
D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis; D000918:Antibody Specificity; D000941:Antigens / Q000737:chemistry* / Q000235:genetics; D002352:Carrier Proteins / Q000138:chemical synthesis / Q000276:immunology; D003432:Cross-Linking Reagents; D005976:Glutaral; D007158:Immunologic Techniques; D010455:Peptides / Q000138:chemical synthesis* / Q000235:genetics / Q000276:immunology*; D011487:Protein Conformation; D011506:Proteins / Q000737:chemistry / Q000276:immunology; D013388:Succinimides
D000911:Antibodies, Monoclonal; D000941:Antigens; D002352:Carrier Proteins; D003432:Cross-Linking Reagents; D010455:Peptides; D011506:Proteins; D013388:Succinimides; C072252:m-maleimidobenzoyl-N-hydroxysulfosuccinimide ester; D005976:Glutaral